Osteopore Ltd
Company Profile
Business description
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.
Contact
2 Tukang Innovation Grove
No. 09-06 and 07, JTC MedTech Hub
Singapore618305
SGPSector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
A closer look at US tech earnings
stocks
Cheap ASX energy share lifts earnings guidance on stronger output
stocks
ASX listed bank overvalued despite strong earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,909.60 | 42.50 | -0.47% |
| CAC 40 | 7,978.85 | 77.53 | -0.96% |
| DAX 40 | 23,997.45 | 352.83 | -1.45% |
| Dow JONES (US) | 49,425.40 | 279.07 | -0.56% |
| FTSE 100 | 10,242.59 | 26.84 | -0.26% |
| HKSE | 26,347.91 | 58.93 | -0.22% |
| NASDAQ | 25,969.53 | 304.60 | -1.16% |
| Nikkei 225 | 62,742.57 | 324.69 | 0.52% |
| NZX 50 Index | 13,080.33 | 130.15 | -0.99% |
| S&P 500 | 7,361.63 | 51.21 | -0.69% |
| S&P/ASX 200 | 8,670.70 | 40.60 | -0.47% |
| SSE Composite Index | 4,214.49 | 10.53 | -0.25% |